Valgerður Rúnarsdóttir

5.4k total citations
25 papers, 372 citations indexed

About

Valgerður Rúnarsdóttir is a scholar working on Epidemiology, Hepatology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Valgerður Rúnarsdóttir has authored 25 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 13 papers in Hepatology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Valgerður Rúnarsdóttir's work include Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Valgerður Rúnarsdóttir is often cited by papers focused on Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Valgerður Rúnarsdóttir collaborates with scholars based in Iceland, Australia and United States. Valgerður Rúnarsdóttir's co-authors include Ingunn Hansdóttir, Þórarinn Tyrfingsson, Sigurður Ólafsson, Einar S. Björnsson, Magnús Gottfreðsson, Margaret Hellard, Ottar M. Bergmann, Sigurður Júlíusson, Unnur Steina Björnsdóttir and Högni Óskarsson and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Hepatology and Journal of Internal Medicine.

In The Last Decade

Valgerður Rúnarsdóttir

24 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Valgerður Rúnarsdóttir Iceland	12	219	138	50	49	38	25	372
Patrizia Pace Italy	7	128 0.6×	17 0.1×	33 0.7×	52 1.1×	30 0.8×	12	290
A.P. Athanasoulia Germany	11	74 0.3×	14 0.1×	41 0.8×	19 0.4×	22 0.6×	19	421
Benjamin King United States	8	174 0.8×	45 0.3×	36 0.7×	45 0.9×	32 0.8×	11	424
Daniel Tracy United States	7	156 0.7×	85 0.6×	6 0.1×	49 1.0×	10 0.3×	9	359
Jafar Nasiri Iran	9	115 0.5×	93 0.7×	8 0.2×	96 2.0×	111 2.9×	25	328
Herbert Csef Germany	8	292 1.3×	336 2.4×	5 0.1×	34 0.7×	105 2.8×	40	613
Alexander Kiderman Israel	11	201 0.9×	22 0.2×	5 0.1×	29 0.6×	11 0.3×	31	358
Philippe Arvers France	12	74 0.3×	64 0.5×	4 0.1×	18 0.4×	11 0.3×	32	356
Emily Nguyen United States	10	100 0.5×	22 0.2×	66 1.3×	27 0.6×	6 0.2×	17	308
Amy Phu Australia	10	65 0.3×	13 0.1×	36 0.7×	91 1.9×	19 0.5×	20	403

Countries citing papers authored by Valgerður Rúnarsdóttir

Since Specialization

Citations

This map shows the geographic impact of Valgerður Rúnarsdóttir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valgerður Rúnarsdóttir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valgerður Rúnarsdóttir more than expected).

Fields of papers citing papers by Valgerður Rúnarsdóttir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valgerður Rúnarsdóttir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valgerður Rúnarsdóttir. The network helps show where Valgerður Rúnarsdóttir may publish in the future.

Co-authorship network of co-authors of Valgerður Rúnarsdóttir

This figure shows the co-authorship network connecting the top 25 collaborators of Valgerður Rúnarsdóttir. A scholar is included among the top collaborators of Valgerður Rúnarsdóttir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valgerður Rúnarsdóttir. Valgerður Rúnarsdóttir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rúnarsdóttir, Valgerður, Eva Halapi, & Þorbjörg Jónsdóttir. (2025). Adverse childhood experiences and health problems in adulthood: A retrospective cross-sectional study. Læknablaðið. 111(6). 269–277. 1 indexed citations

Björnsson, Einar S., et al.. (2023). Development of severe alcohol related liver disease over four decades in Iceland: impact of increased access and use of alcohol. Scandinavian Journal of Gastroenterology. 58(12). 1523–1533. 2 indexed citations

Gottfreðsson, Magnús, Valgerður Rúnarsdóttir, Þorvarður Jón Löve, et al.. (2022). Sustained low prevalence of HCV viremia among people who inject drugs following the treatment as prevention for hepatitis C (TraP HepC) nationwide elimination program in Iceland. Journal of Hepatology. 77. S573–S573. 1 indexed citations

Ólafsson, Sigurður, Þorvarður Jón Löve, Þórarinn Tyrfingsson, et al.. (2021). Cascade of care during the first 36 months of the treatment as prevention for hepatitis C (TraP HepC) programme in Iceland: a population-based study. The Lancet. Gastroenterology & hepatology. 6(8). 628–637. 18 indexed citations

Ólafsson, Sigurður, Þórarinn Tyrfingsson, Valgerður Rúnarsdóttir, et al.. (2019). THU-412-Iceland may already have reached the WHO 2030 targets for diagnosis and treatment of hepatitis C virus infection: Results from the treatment as prevention for hepatitis C (Trap HepC) program. Journal of Hepatology. 70(1). e337–e338. 8 indexed citations

Gottfreðsson, Magnús, Valgerður Rúnarsdóttir, Þorvarður Jón Löve, et al.. (2019). 2895. Threats to Successful Elimination of Viral Hepatitis: Results from the Nationwide Treatment as Prevention for Hepatitis C (TraP HepC) Program in Iceland. Open Forum Infectious Diseases. 6(Supplement_2). S81–S82. 1 indexed citations

Júlíusson, Sigurður, et al.. (2018). Lifetime alcohol intake and pattern of alcohol consumption in patients with alcohol-induced pancreatitis in comparison with patients with alcohol use disorder. Scandinavian Journal of Gastroenterology. 53(6). 748–754. 12 indexed citations

Kakko, Johan, Mikael Sandell, Thomas Clausen, et al.. (2018). Principles for managing OUD related to chronic pain in the Nordic countries based on a structured assessment of current practice. Substance Abuse Treatment Prevention and Policy. 13(1). 22–22. 7 indexed citations

Tyrfingsson, Þórarinn, Valgerður Rúnarsdóttir, Ingunn Hansdóttir, et al.. (2018). Marked reduction in the prevalence of hepatitis C viremia among people who inject drugs during 2nd year of the Treatment as Prevention (TraP HepC) program in Iceland. Journal of Hepatology. 68. S52–S52. 4 indexed citations

10.

Gottfreðsson, Magnús, Þórarinn Tyrfingsson, Valgerður Rúnarsdóttir, et al.. (2018). 928. Major Decrease in Prevalence of Hepatitis C Viremia in Key Populations following the Second Year of Treatment as Prevention for Hepatitis C (TraP HepC) Program in Iceland. Open Forum Infectious Diseases. 5(suppl_1). S30–S30. 1 indexed citations

11.

Ólafsson, Sigurður, et al.. (2017). Lifetime drinking history in patients with alcoholic liver disease and patients with alcohol use disorder without liver disease. Scandinavian Journal of Gastroenterology. 52(6-7). 762–767. 21 indexed citations

12.

Rúnarsdóttir, Valgerður, Ingunn Hansdóttir, Þórarinn Tyrfingsson, et al.. (2017). Extended-Release Injectable Naltrexone (XR-NTX) With Intensive Psychosocial Therapy for Amphetamine-Dependent Persons Seeking Treatment: A Placebo-Controlled Trial. Journal of Addiction Medicine. 11(3). 197–204. 20 indexed citations

13.

Ólafsson, Sigurður, Þórarinn Tyrfingsson, Valgerður Rúnarsdóttir, et al.. (2017). Treatment as prevention for hepatitis C in Iceland (TRAP HEP C). A real-world experience from a nationwide elimination program using direct acting antiviral agents. Journal of Hepatology. 66(1). S72–S72. 2 indexed citations

14.

Reginsson, Gunnar W., Andrés Ingason, Jack Euesden, et al.. (2017). Polygenic risk scores for schizophrenia and bipolar disorder associate with addiction. Addiction Biology. 23(1). 485–492. 75 indexed citations

15.

Scott, Nick, Sigurður Ólafsson, Magnús Gottfreðsson, et al.. (2017). Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020. Journal of Hepatology. 68(5). 932–939. 39 indexed citations

16.

Gottfreðsson, Magnús, Þórarinn Tyrfingsson, Valgerður Rúnarsdóttir, et al.. (2017). Treatment as Prevention for Hepatitis C (TraP HepC). A Real-world Experience from the First 12 Months of a Nationwide Elimination Program in Iceland. Open Forum Infectious Diseases. 4(suppl_1). S42–S42. 4 indexed citations

17.

Taylor, Lynn E., Grace Macalino, Michelle McKenzie, et al.. (2003). Would You Consider Prescribing Syringes to Injection Drug Users?. Journal of Addictive Diseases. 22(1). 67–78. 3 indexed citations

18.

Björnsdóttir, Unnur Steina, et al.. (2003). The effect of reducing levels of cat allergen (Fel d 1) on clinical symptoms in patients with cat allergy. Annals of Allergy Asthma & Immunology. 91(2). 189–194. 28 indexed citations

19.

Rich, Josiah D., Tom L. Whitlock, Christopher W. Towe, et al.. (2001). PRESCRIBING SYRINGES TO PREVENT HIV: A SURVEY OF INFECTIOUS DISEASE AND ADDICTION MEDICINE PHYSICIANS IN RHODE ISLAND. Substance Use & Misuse. 36(5). 535–550. 16 indexed citations

20.

Mylonakis, Eleftherios, Douglas Shemin, Valgerður Rúnarsdóttir, et al.. (1999). Survival of a human immunodeficiency patient with nucleoside-induced lactic acidosis—role of haemodialysis treatment. Nephrology Dialysis Transplantation. 14(10). 2484–2486. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact